Physician profile
Ryan Squier
NPI 1295051894
$1,454.52
in general payments reported to CMS, 2019-2025
12 companies · $217 in 2025
The $217 reported for 2025 was more than what 84% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2021: $50.68 · 2022: $386 · 2023: $346 · 2024: $251 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $794 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $793.84 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $330.21 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $197.77 | 2019-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $186.84 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $172.80 | 2021-2023 | Andexxa, Lokelma |
| Boston Scientific Corporation | $165.58 | 2024-2025 | Watchman Flx |
| Csl Behring | $134.04 | 2019-2024 | Kcentra |
| Portola Pharmaceuticals, LLC | $105.55 | 2019 | |
| Melinta Therapeutics, LLC | $51.18 | 2019 | |
| Abbott Laboratories | $43.38 | 2024 | I-Stat |
| Bioxcel Therapeutics, INC. | $27.56 | 2023 | Igalmi |
| Ucb, INC. | $20.36 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $19.25 | 2025 | Uptravi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Squier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.